Back to results
Active, not recruitingPhase 1Phase 2

ALSENLITE: Senolytics for Alzheimer's Disease

NCT04785300

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View on ClinicalTrials.gov
ALSENLITE: Senolytics for Alzheimer's Disease — TrialFind